A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Mary Sano(James J. Peters VA Medical Center), Leon J. Thal(Johns Hopkins University)
Cited by 2,380
Related Papers
Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis
|Proceedings of the National Academy of Sciences|2018|103